From: TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report
Parameter | Value (reference range) | Parameter | Value (reference range) |
---|---|---|---|
Hematology | Coagulation | ||
WBC | 12,050/μL (4000–9000) | INR | 1.16 (0.85–1.15) |
RBC | 291 × 104/μL (380–500 × 104) | APTT | 46.1 s (26.1–46.1) |
Hb | 8.7 g/dL (11.5–15.0) | Fib | 420 mg/dl (150–450) |
Ht | 27.3% (35.0–46.0) | D-dimer | 4.59 μg/dl (< 0.5) |
PLT | 7.2 × 104/μL (15.0–35.0 × 104) | ||
Serology | |||
Biochemistry | IgG | 2278 mg/dl (870–1700) | |
TP | 7.0 g/dL (6.6–8.1) | IgA | 132 mg/dl (110–410) |
Alb | 2.8 g/dL (4.1–5.1) | IgM | 158 mg/dl (35–220) |
AST | 20 IU/L (13–30) | C3 | 95 mg/dl (86–160) |
ALT | 8 IU/L (7–23) | C4 | 20 mg/dl (17–45) |
ALP | 92 IU/L (38–113) | CH50 | 54.8U/ml (31.6–57.6) |
GTP | 15 IU/L (9–32) | ADAMTS13 | 34% (> 10) |
LDH | 194 IU/L (124–222) | IL-6 | 14.8 pg/ml (0–4.0) |
BUN | 29 mg/dl (8–20) | VEGF | 384 pg/ml (0–38.3) |
Cr | 1.07 mg/dl (0.46–0.79) | ANA | 40 (< 40) |
eGFR | 41 ml/min/1.73m2 | SS-A Ab | 821U/ml (0–10.0) |
UA | 8.0 mg/dl (2.6–7.0) | SS-B Ab | 4.9U/ml (0–10.0) |
Na | 136 mEq/L (138–145) | MPO-ANCA | < 1.0EU (< 1.0) |
K | 4.4 mEq/L (3.6–4.8) | PR3-ANCA | < 1.0EU (< 1.0) |
Cl | 101 mEq/L (101–108) | s-IL2R | 2046U/ml (122–496) |
CRP | 3.33 mg/dl (< 0.3) | Haptoglobin | 212 mg/dl (15–116) |
Glucose | 98 mg/dl (70–109) | Cryoglobulin | - |
HbA1c | 4.6% (4.6–6.2) | TSPOT | - |
HHV8 | - | ||
Urinalysis | syphilis | - | |
Protein | 2 + | HBs Ag | - |
Occult blood | - | HCV Ab | - |
UTP/UCr | 0.78 g/gCr | HIV | - |
β2MG | 316 ng/ml (< 150) | M protein | negative |
BJP | negative |